Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
August 28, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3830931 Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof Method for improving the metabolic stability and survival of neonatal pigs Nutrient solution for complete parenteral feeding and for increased energy production Amino acid preparation and therapy for treatment of stress and injury Virucidal compositions and therapy Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions Controlled triglyceride nutrition for hypercatabolic mammals Infusion solution for parenteral nutrition Method for directed visceral metabolism of medium chain triglycerides Inventors
AssigneeApplicationNo. 403849 filed on 08/28/1989US Classes:514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/23, Carbohydrate (i.e., saccharide radical containing) DOAI514/558, Higher fatty acid or salt thereof514/560, Carbon to carbon unsaturation514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/562, Sulfur nonionically bonded514/564, Plural nitrogens nonionically bonded514/824, ARTERIOSCLEROSIS514/943Higher fatty acid or derivative containingExaminersPrimary: Stone, JacquelineAttorney, Agent or FirmForeign Patent References
International ClassesA61K 037/02A61K 031/195 A61K 031/715 AbstractA method is provided for individuals under treatment for or at risk of atherosclerotic, vascular, cardiovascular, and/or thrombotic disease by administering a composition which comprises a protein source; a carbohydrate source; and at least one lipid selected from the group consisting of: gamma-linolenic acid; eicosapentaenoic acid; docosahexaenoic acid; sterodonic acid; and linolenic acid. Both an enteral and parenteral composition are provided.Other References
Field of SearchCarbon to carbon unsaturationNitrogen other than as nitro or nitroso nonionically bonded Higher fatty acid or salt thereof Sulfur nonionically bonded Plural nitrogens nonionically bonded ARTERIOSCLEROSIS Higher fatty acid or derivative containing Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI Carbohydrate (i.e., saccharide radical containing) DOAI | |
